Message from President Daniels: Medicine dean/CEO search committee

Dear Faculty, Staff and Students:

As I announced last week, Edward Miller will retire on June 30, 2012, from his position as dean of the medical faculty of the School of Medicine, CEO of Johns Hopkins Medicine and vice president for medicine at The Johns Hopkins University. I have asked Frank Burch, the incoming chair of the Johns Hopkins Medicine Board of Trustees, and Lloyd Minor, provost and senior vice president for academic affairs, to co-chair the search for this important leadership position.

This transition occurs at a pivotal time in the history of Johns Hopkins Medicine. There are many successes, which establish a firm foundation for the future. Likewise, there are challenges faced by Johns Hopkins Medicine, and, indeed, by all academic medical centers, that merit close and continued examination. The search process provides a critically important mechanism for evaluating these challenges and opportunities.

The next dean of the School of Medicine and CEO of Johns Hopkins Medicine will work collaboratively and in partnership with Provost Minor and me, with the president of The Johns Hopkins Hospital and Health System, as well as with the boards of Johns Hopkins Medicine and The Johns Hopkins University, other academic deans and senior administrative officers to advance our shared priorities and pursuit of excellence. She or he will lead Johns Hopkins Medicine to ensure its continued preeminence in education, discovery and patient care.

I have appointed a search committee to assist in identifying Dr. Miller's successor and to undertake an exhaustive international search to identify suitable candidates for the position. You will find below my signature the names of the search committee members and some background material on each of them.

As this search process gets under way, I invite you to submit your thoughts or nominations — all of which will be kept in the strictest confidence — to the search committee at somdeansearch@jhu.edu.

Sincerely,

Ronald J. Daniels

*********************

Francis B. (Frank) Burch Jr., Co-Chair. Mr. Burch is the chairman of DLA Piper. He has helped lead the evolution of what was once Piper & Marbury, a regional firm based in Maryland with 250 lawyers, to DLA Piper, a firm with more than 4,000 lawyers in 30 countries and revenue that will exceed $2.6 billion in 2011. He has been recognized in Chambers USA: America's Leading Lawyers for Business, The Best Lawyers in America (for business litigation) and in the Best Lawyers Annual Guide to Commercial Litigation 2010. He is a fellow of the American College of Trial Lawyers and a member of the American Law Institute. In July 2011, Mr. Burch will begin his service as chairman of the Board of Trustees of Johns Hopkins Medicine, of which he has been a member since its inception in 1996. He will continue to serve on the Johns Hopkins University Board of Trustees, which he joined in 2005. He also serves as a director of the Leadership Council for Legal Diversity.

Lloyd B. Minor, Co-Chair. Dr. Minor is provost and senior vice president for academic affairs and university distinguished service professor of otolaryngology–head and neck surgery. He also holds faculty appointments in the Department of Neuroscience and Department of Biomedical Engineering. A member of the faculty of the Johns Hopkins School of Medicine since 1993, he was the Andelot Professor and director of otolaryngology–head and neck surgery from 2003 to 2009, when he became provost. Dr. Minor also held leadership roles in the School of Medicine as chair of the Administrative Committee of the Medical Board and chair of the Practice Management Committee.

Jeffrey H. Aronson is co-founder and managing principal of Centerbridge Partners L.P., a private investment firm based in New York City. Mr. Aronson is a member of the Johns Hopkins University Board of Trustees, serving on the Executive Committee and chairing the Development Committee. He also chairs the advisory council of the Krieger School of Arts and Sciences and serves on the advisory council of the Krieger School's Center for Financial Economics. He will join the Board of Trustees of Johns Hopkins Medicine on July 1. Mr. Aronson graduated with honors from Johns Hopkins and has a J.D. from New York University School of Law.

Janie Elizabeth (Liza) Bailey has served on the Johns Hopkins Medicine board since 2005, serving as a member of the Executive Committee and Finance Committee and chairing the Audits, Compliance and Insurance Committee. She is also a member of the Johns Hopkins University and Johns Hopkins Health System boards of trustees. A third great-niece of Mr. Johns Hopkins, Mrs. Bailey was one of 12 collateral descendants of the university and hospital's founder who endowed the Johns Hopkins Family Professorship in Oncology Research. Mrs. Bailey is a retired managing director of Credit Suisse First Boston, where she focused on mergers and acquisitions among food, beverage and personal care industry clients in the Americas.

Patricia M. C. Brown is president of Johns Hopkins HealthCare LLC and Johns Hopkins Employer Health Plans. She served as Johns Hopkins Medicine's first senior director of managed care and is a former assistant attorney general of the State of Maryland and past president of the Maryland State Bar Association's Health Care Law Section Council. Ms. Brown began her career at the Johns Hopkins Health System as senior legal counsel for patient care advice and regulatory issues in 1994. Prior to joining Johns Hopkins, in the Maryland Office of the Attorney General, Department of Health and Mental Hygiene, she acted as counsel to the Maryland Medical Assistance Program, the Maryland Health Resources Planning Commission and the Maryland Board of Dental Examiners.

George L. Bunting Jr. is chairman and chief executive officer of Bunting Management Group in Hunt Valley, Md., and former chairman of the board and chief executive officer of Noxell Corp. He was instrumental in the creation of Johns Hopkins Medicine, has continually served on its Board of Trustees since it was established in 1996 and chaired the board from 1996 to 1998. Mr. Bunting has been a Johns Hopkins University trustee since 1985 and served as vice chair of the board from 1996 to 1998. He has been a longstanding member of the boards of trustees of the Johns Hopkins Health System and The Johns Hopkins Hospital, having served as chair of both boards from 1994 to 1998. In addition, he co-chaired the highly successful Johns Hopkins Knowledge for the World Campaign from 2000 to 2006. Mr. Bunting's steadfast support is visible across Johns Hopkins, from the Bunting-Blaustein Cancer Research Building in East Baltimore to the Bunting?Meyerhoff Interfaith and Community Service Center on the Homewood campus.

Jacquelyn C. (Jackie) Campbell is the Anna D. Wolf Professor, Department of Community-Public Health, School of Nursing (joint appointment, Bloomberg School of Public Health). Dr. Campbell's research on domestic and intimate partner violence is highly influential in the field and among public policymakers. She was elected to the Institute of Medicine in 2000 and this year was named one of the university's first Gilman Scholars. She has been honored with the Distinguished Scholar Award of the Academy on Violence and Abuse for advancing education and research in the field.

Benjamin S. Carson Sr. is professor of neurosurgery, oncology, plastic surgery and pediatrics and director of the Division of Pediatric Neurosurgery, School of Medicine. Dr. Carson is also co-director of the Craniofacial Center. He is widely known for innovative and groundbreaking neurosurgical procedures for children. He was awarded the Presidential Medal of Freedom in 2008 for his contributions not only as a physician but also as a philanthropist, author, mentor and motivator who works with youth to help them reach their full potential regardless of circumstances.

N. Anthony (Tony) Coles is president, chief executive officer and member of the Board of Directors of Onyx Pharmaceuticals Inc. in northern California. Prior to joining Onyx, he held a similar position at NPS Pharmaceuticals, and before that held executive positions at Vertex Pharmaceuticals, Bristol-Myers Squibb Co. and Merck & Co. Dr. Coles serves as a trustee and a member of the Executive Committee of the Johns Hopkins University Board of Trustees and chaired the Governance Initiative Steering Committee. He joined the Johns Hopkins Medicine Board of Trustees in 2010 and is a former chair of the Krieger School of Arts and Sciences Advisory Council. Dr. Coles is a member of the Board of Directors for Laboratory Corp. of America (LabCorp) and Campus Crest Communities Inc., both NYSE-traded companies. He is a member of the board of the Biotechnology Industry Organization. Dr. Coles earned his M.D. from Duke University, a master's in public health from Harvard University and his undergraduate degree from Johns Hopkins.

Lisa A. Cooper is a professor of medicine in the School of Medicine with joint appointments in the Bloomberg School of Public Health and School of Nursing. Dr. Cooper is an internist and epidemiologist with a focus on understanding and reversing racial and ethnic disparities in disease and health care. She was a 2007 winner of a John D. and Catherine T. MacArthur Foundation fellowship, popularly known as a "genius grant." This year, Dr. Cooper was named a member of the university's inaugural class of Gilman Scholars. She was elected to the Institute of Medicine in 2008.

J. Raymond (Ray) DePaulo Jr. is the Henry Phipps Professor and director of the Department of Psychiatry and Behavioral Sciences in the School of Medicine. Dr. DePaulo is among the most influential clinicians and researchers worldwide on the causes and treatments of depression and bipolar disorder. A member of the Johns Hopkins faculty since 1977 and department director since 2002, he founded clinics and later the Johns Hopkins Center for Mood Disorders. The Johns Hopkins Center was a founding member of the National Network of Depression Centers in 2009, and Dr. DePaulo is vice chair of the Board of Directors. He has published more than 100 papers on genetic causes of bipolar disorder as well as two books on depression for patients and families.

Carol Greider is the Daniel Nathans Professor and director of the Department of Molecular Biology and Genetics in the Institute for Basic Biomedical Sciences at the School of Medicine. Dr. Greider, a pioneering researcher on the structure of chromosome ends known as telomeres, shared the 2009 Nobel Prize in physiology or medicine for her 1984 discovery of telomerase. She is a member of the Institute of Medicine, the American Academy of Arts and Sciences, and the National Academy of Sciences; she won the Albert Lasker Award for Basic Medical Research in 2006. Dr. Greider was appointed this year to the university's inaugural class of Gilman Scholars.

Diane E. Griffin is the Alfred and Jill Sommer Professor and chair of the Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health (joint appointment, School of Medicine). Dr. Griffin's research focuses on how disease is caused by viruses, especially alpha-viruses, acute encephalitis and measles. She was the founding director of the Malaria Research Institute and was one of the first class of 17 Gilman Scholars named this year. Dr. Griffin is also a member of the National Academy of Sciences, the American Academy of Microbiology and the Institute of Medicine.

Michael D. Hankin is president and chief executive officer of Brown Advisory Holdings Inc. A trustee of Johns Hopkins Medicine, he sits on the Executive Committee, chairs the Finance Committee, and serves on the Subcommittee on Debt Capacity and Debt Financing. He will become a member of the Johns Hopkins University Board of Trustees on July 1. Mr. Hankin also chairs the Johns Hopkins University Carey Business School Corporate Advisory Board and serves on the Jhpiego Advisory Council. Mr. Hankin is a trustee of several private foundations as well as a trustee of the Baltimore Community Foundation, chairman of the Baltimore Waterfront Partnership, president of Land Preservation Trust Inc., and a past chairman of the Board of Trustees of the Maryland Zoological Society (The Maryland Zoo). He was formerly a partner with the law firm of Piper & Marbury in Baltimore.

David C. Hodgson is a managing director of General Atlantic LLC in New York and has been with the firm since 1982. He graduated summa cum laude from Dartmouth College with a degree in mathematics and social sciences and is a member of Phi Beta Kappa. Mr. Hodgson received an MBA from the Stanford University Graduate School of Business. He is a member of the Board of Trustees of Johns Hopkins Medicine, where he serves on the Development Committee; the board of advisors of Johns Hopkins Medicine; and the Board of Trustees of The Johns Hopkins University, where he serves on the Development, Finance and Investment committees. He has been an ardent supporter of basic science and cognitive neuroscience research at Johns Hopkins Medicine.

Michael I. Miller is the Herschel and Ruth Seder Professor in the Department of Biomedical Engineering in the Whiting School of Engineering. Dr. Miller, director of the Center for Imaging Science, is a pioneer in the areas of image understanding, pattern theory, computer vision, medical imaging/computational anatomy and computational neuroscience. He won a Presidential Young Investigator Award in 1986. In 2003, Dr. Miller received the International Man of the Year Award from the International Biographical Center in Cambridge, England. He has co-authored more than 100 peer-reviewed archival publications and is the co-author of two textbooks, Random Point Processes in Space and Time and Pattern Theory: From Representation to Inference. Dr. Miller was named in 2011 to the first class of 17 Gilman Scholars.

Erin M. Parry is a fifth-year M.D./Ph.D. student in the Johns Hopkins University School of Medicine graduate program in human genetics. She received her bachelor's degree in biology with a minor in mathematics from Colby College. Ms. Parry has been a summer intern at the National Human Genome Research Institute and a teaching assistant and tutor for part of the year 1 medical school curriculum. In the School of Medicine, she is currently a peer advisor in Thomas College and co-leader of the student interest group in oncology. She previously served as a student leader on the School of Medicine Admissions Committee and the Colleges Leadership Council and was co-chair of the Peer Advising Program, among several other leadership activities.

Beverly Wendland is professor and chair of the Department of Biology in the Krieger School of Arts and Sciences. Dr. Wendland's research focus is on conserved molecular mechanisms and regulation of endocytic vesicle formation, using the baker's yeast as a model system. A member of the Johns Hopkins faculty since 1998 and a full professor since 2008, she has been a recipient of the Burroughs Wellcome Fund New Investigator Award in the Pharmacological Sciences and the March of Dimes Basil O'Connor Award. Her research is currently supported by grants from the NIH and the NSF; she is also the principal investigator of an NIH training grant for the Cellular, Molecular and Developmental Biology and Biophysics (CMDB) Graduate Training Program. She received a B.S. in bioengineering from University of California, San Diego, and a Ph.D. in neurosciences from Stanford University.

Myron (Mike) Weisfeldt is the William Osler Professor and director of the Department of Medicine, a position he has held since 2001. Prior to assuming these positions, he was chairman of the Department of Medicine and director of the medical service at Columbia-Presbyterian Medical Center in New York. From 1975 to 1991, he was director of Cardiology at Johns Hopkins. A past president of the American Heart Association, Dr. Weisfeldt has conducted research on cardiopulmonary resuscitation, sudden cardiac death, acute myocardial infarction and acute ischemic syndromes, and age-associated changes in cardiovascular function and response to stress. His work has directly influenced the modernization of guidelines for CPR and advanced cardiac life support. Dr. Weisfeldt also has led efforts to make automated external cardiac defibrillators more widely available in public places where heart attacks occur. A member of the Institute of Medicine, he was the second recipient of the Diversity Award of the Association of Professors of Medicine in recognition of his initiatives to increase diversity among residents, fellows and faculty in his department.